Session

Basic science in pancreatic disease

SELECTIVE ELIMINATION OF CD133+ CANCER STEM CELLS AS THERAPY FOR PDAC USING NOVELDUAL BET/HDAC INHIBITOR TW09
SELECTIVE ELIMINATION OF CD133+ CANCER STEM CELLS AS THERAPY FOR PDAC USING NOVELDUAL BET/HDAC INHIBITOR TW09

CXCL12 – CXCR4 SIGNALING IS IMPERATIVE FOR MAINTENANCE AND METASTATIC PROPENSITY OF MIGRATING CANCER STEM CELLS
CXCL12 – CXCR4 SIGNALING IS IMPERATIVE FOR MAINTENANCE AND METASTATIC PROPENSITY OF MIGRATING CANCER STEM CELLS

OLAPARIB AND TRAIL-TARGETING AGENTS SYNERGIZE IN PANCREATIC CANCER INDEPENDENT OF DNA DAMAGE REPAIR STATUS
OLAPARIB AND TRAIL-TARGETING AGENTS SYNERGIZE IN PANCREATIC CANCER INDEPENDENT OF DNA DAMAGE REPAIR STATUS

HARNESSING PLURIPOTENT STEM CELL DERIVED TRILINEAGE-COMPETENT PANCREATIC PROGENITORS TO GENERATE DUCT-LIKE ORGANOIDS
HARNESSING PLURIPOTENT STEM CELL DERIVED TRILINEAGE-COMPETENT PANCREATIC PROGENITORS TO GENERATE DUCT-LIKE ORGANOIDS

SPCA2/STIM1 TRIGGERED CONSTITUTIVE ACTIVITY OF ORAI1 CA2+CHANNEL FINE-TUNES CFTR IN SECRETORY EPITHELIAL CELLS
SPCA2/STIM1 TRIGGERED CONSTITUTIVE ACTIVITY OF ORAI1 CA2+CHANNEL FINE-TUNES CFTR IN SECRETORY EPITHELIAL CELLS

Basic science in pancreatic disease

HARNESSING PLURIPOTENT STEM CELL DERIVED TRILINEAGE-COMPETENT PANCREATIC PROGENITORS TO GENERATE DUCT-LIKE ORGANOIDS
HARNESSING PLURIPOTENT STEM CELL DERIVED TRILINEAGE-COMPETENT PANCREATIC PROGENITORS TO GENERATE DUCT-LIKE ORGANOIDS

Basic science in pancreatic disease  et al.

OLAPARIB AND TRAIL-TARGETING AGENTS SYNERGIZE IN PANCREATIC CANCER INDEPENDENT OF DNA DAMAGE REPAIR STATUS
OLAPARIB AND TRAIL-TARGETING AGENTS SYNERGIZE IN PANCREATIC CANCER INDEPENDENT OF DNA DAMAGE REPAIR STATUS

Basic science in pancreatic disease  et al.

CXCL12 – CXCR4 SIGNALING IS IMPERATIVE FOR MAINTENANCE AND METASTATIC PROPENSITY OF MIGRATING CANCER STEM CELLS
CXCL12 – CXCR4 SIGNALING IS IMPERATIVE FOR MAINTENANCE AND METASTATIC PROPENSITY OF MIGRATING CANCER STEM CELLS

Basic science in pancreatic disease  et al.

SELECTIVE ELIMINATION OF CD133+ CANCER STEM CELLS AS THERAPY FOR PDAC USING NOVELDUAL BET/HDAC INHIBITOR TW09
SELECTIVE ELIMINATION OF CD133+ CANCER STEM CELLS AS THERAPY FOR PDAC USING NOVELDUAL BET/HDAC INHIBITOR TW09

Basic science in pancreatic disease  et al.

Item 1 - 9 / 9
1